HR Execs on the Move

Tetraphase

www.tphase.com

 
Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase`s proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol `TTPH.` Tetraphase is well positioned to be a major player in the multidrug-resistant arena.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.tphase.com
  • 480 Arsenal Street Suite 110
    Watertown, MA USA 02472
  • Phone: 617.715.3600

Executives

Name Title Contact Details

Similar Companies

Anchen Pharmaceuticals Inc

Anchen Pharmaceuticals Inc is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Merz

Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of

WRS

Stone and Magnanini

Stone & Magnanini is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RSA Americas

RSA Americas is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.